20
Laurus Labs Private Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Oxaliplatin, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2009-263 - Rev 02
This Chemical Type CEP, issued on April 05, 2012, remains in force until September 07, 2015, ensuring its reliability within the pharmaceutical industry.
Substance Number 2017 associated with this CEP further emphasizes